Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine, Cyclophosphamide, and Etoposide for Acute Leukemia with MRD
NCT02349178Phase 2Terminated
- Sponsor
- Medical College of Wisconsin
- Start
- Dec 2014
- Primary completion
- Mar 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine, cyclophosphamide, etoposide in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), sponsored by Medical College of Wisconsin. Started Dec 2014; status: terminated.
02
Drugs
clofarabinecyclophosphamideetoposide
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT02349178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02349178.